Info@ThinkPinkRocks.com

No lasting metabolic health costs from combined GH and GnRH analogue therapy

Gonadotropin-releasing hormone analogue given alongside growth hormone during puberty in order to increase adult height does not have long-term metabolic health consequences in children born small for gestational age, research shows.

Continue reading here:
No lasting metabolic health costs from combined GH and GnRH analogue therapy

Share

Leave a Reply